Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation
Key facts
- Who runs it
- East Coast Institute for Research
- Where
- Jacksonville, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 101 people enrolled
- Started
- 10 Jul 2023
- Ended
- 23 Jul 2024
- Type of study
- Observational
- Record updated
- 10 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Age ≥ 18 years
- History of adult cataract and uneventful, refractive cataract surgery with Clareon® Vivity® or Vivity® Toric intraocular lens (IOL) implantation with manifest refraction spherical equivalent (MRSE) within ±1.00 D
- Willing to undergo an eye exam with pupil dilation
Who cannot take part
- Yttrium aluminum garnet (YAG) laser capsulotomy within 1 month prior to enrollment
- Laser-assisted in situ keratomileusis (LASIK) or photorefractive keratectomy (PRK) within the one year prior to IOL implantation or any time after IOL implantation
- Any previous ocular surgery (excluding YAG, LASIK, PRK)
- Any additional procedure(s) at the same time as the Vivity implantation including but not limited to microinvasive glaucoma surgery (MIGS)
- Clinically significant ocular pathology; severe diabetic retinopathy, age-related macular degeneration (AMD), glaucoma, severe dry eye, irregular astigmatism, zonular weakness, pseudoexfoliation, ocular trauma
- Moderate to severe posterior capsule opacification (2+ or more)
- Women who are pregnant at the time of screening (based on self-reported history)
- Medical or other problems which in the opinion of the investigator will render study participation unsafe
Where in United States
- East Coast Institute for ResearchJacksonville, United States
About the trial
What the trial wants to find out
The goal of this observational study is to assess the effect of intraocular lens (IOL) movement in patients who have undergone Clareon® Vivity® IOL implantation.
Read full original descriptionShow less
The main question it aims to answer is: Does an association exist between IOL movement and patient quality of vision?
Participants implanted with Clareon® Vivity® and Vivity® Toric IOLs will be asked to do the following:
* consent to participate in the study * allow researchers to access their personal medical records * undergo a series of tests to assess the position of their IOLs and quality of vision
Researchers will assess participant examination results to determine whether an association exists between IOL movement and patient quality of vision.
The group in the trial
- Individuals implanted with Clareon® Vivity® or Vivity® Toric Intraocular Lenses (IOLs)
Individuals who have a history of adult cataract and uneventful, refractive cataract surgery with Clareon® Vivity® or Vivity® Toric IOL implantation with MRSE within ±1.00 D.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Non-Interventional Study to Evaluate the Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance in Patients Who Have Undergone Clareon® Vivity® IOL Implantation
- Record updated
- 10 July 2026